Glycosylated hemoglobin A: Difference between revisions
imported>Robert Badgett No edit summary |
imported>Robert Badgett No edit summary |
||
| Line 20: | Line 20: | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=18258329 | doi=10.1016/j.diabres.2008.01.001 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref> This difference may be as high as 5 mmol/L difference in untreated diabetics (in the UGDP trial).<ref name="pmid10539796">{{cite journal| author=Feinglos MN, Bethel MA| title=Therapy of type 2 diabetes, cardiovascular death, and the UGDP. | journal=Am Heart J | year= 1999 | volume= 138 | issue= 5 Pt 1 | pages= S346-52 | pmid=10539796 |doi=10.1016/S0002-8703(99)70034-7 | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=18258329 | doi=10.1016/j.diabres.2008.01.001 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref> This difference may be as high as 5 mmol/L difference in untreated diabetics (in the UGDP trial).<ref name="pmid10539796">{{cite journal| author=Feinglos MN, Bethel MA| title=Therapy of type 2 diabetes, cardiovascular death, and the UGDP. | journal=Am Heart J | year= 1999 | volume= 138 | issue= 5 Pt 1 | pages= S346-52 | pmid=10539796 |doi=10.1016/S0002-8703(99)70034-7 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=10539796 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref> | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=10539796 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref> | ||
Elevated hemoglobin A1c independently predicts outcome, even among patients without diabetes.<ref>NEJM 2010 [http://content.nejm.org/cgi/content/short/362/9/800 Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults]</ref> | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 07:59, 4 March 2010
Glycosylated hemoglobin A, also referred to by it medically most important component Hb A1c, is blood test used to monitor the treatment of diabetes mellitus type 1 and diabetes mellitus type 2. Glycosylated hemoglobin A are "minor hemoglobin components of human erythrocytes designated A1a, A1b, and A1c. Hemoglobin A1c is most important since its sugar moiety is glucose covalently bound to the terminal amino acid of the beta chain. Since normal glycohemoglobin concentrations exclude marked blood glucose fluctuations over the preceding three to four weeks, the concentration of glycosylated hemoglobin A is a more reliable index of the blood sugar average over a long period of time."[1]
The following table helps convert Hb A1c values to average daily blood glucose levels.[2]
- 5% = 97 mg/dL
- 6% = 126 mg/dL (6.99 mmol/L)
- 7% = 154 mg/dL (8.54 mmol/L)
- 8% = 183 mg/dL (10.16 mmol/L)
- 9% = 212 mg/dL (11.77 mmol/L)
- 10% = 240 mg/dL
- 11% = 269 mg/dL
- 12% = 298 mg/dL
For each 1% change in HbA1c approximates a 30 mg/dL (2 mmol/L) change in the average daily glucose.[2]
Older studies obtained different values.[3]
There is approximately 1 mmol/L between the fasting and postprandial glucose levels in treated diabetics.[4] This difference may be as high as 5 mmol/L difference in untreated diabetics (in the UGDP trial).[5]
Elevated hemoglobin A1c independently predicts outcome, even among patients without diabetes.[6]
References
- ↑ Anonymous (2024), Glycosylated hemoglobin A (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ 2.0 2.1 Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ (August 2008). "Translating the A1C assay into estimated average glucose values". Diabetes Care 31 (8): 1473–8. DOI:10.2337/dc08-0545. PMID 18540046. Research Blogging.
- ↑ Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A (1976). "Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus.". N Engl J Med 295 (8): 417-20. PMID 934240.
- ↑ Pupillo M, De Berardis G, Antenucci D, Minnucci A, Nicolucci A (2008). "Glycated haemoglobin or mean blood glucose as indicators of metabolic control in Type 2 diabetes?". Diabetes Res Clin Pract 80 (3): e1-3. DOI:10.1016/j.diabres.2008.01.001. PMID 18258329. Research Blogging.
- ↑ Feinglos MN, Bethel MA (1999). "Therapy of type 2 diabetes, cardiovascular death, and the UGDP.". Am Heart J 138 (5 Pt 1): S346-52. DOI:10.1016/S0002-8703(99)70034-7. PMID 10539796. Research Blogging.
- ↑ NEJM 2010 Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults